A RELATIVE BIOAVAILABILITY STUDY OF THE GRAZOPREVIR/ELBASVIR FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS

被引：0

作者：

Davit, B. M. ^{[1
]}

Alon, A. ^{[1
]}

Caro, L. ^{[2
]}

Feng, H. ^{[2
]}

Guo, Z. ^{[2
]}

Kesisoglou, F. ^{[2
]}

机构：

[1] Merck Res Labs, Rahway, NJ USA

[2] Merck Res Labs, N Wales, PA USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PI-137

引用

页码：S66 / S67

页数：2

共 50 条

[31] Bioavailability of dual therapy: A fixed-dose combination tablet of amlodipine and atorvastatin [J].

Chung, M ;

Randinitis, E ;

Calcagni, A ;

Bramson, C ;

Glue, P .

ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) :173-173

[32] Relative bioavailabffity of fixed-dose combination of antituberculosis drugs in human [J].

Zhao, W.-J. ;

Duan, L.-S. ;

Li, H.-W. ;

Liang, G.-F. ;

Lu, Y. .

Chinese Pharmaceutical Journal, 2001, 36 (08) :545-547

[33] Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules [J].

Zwolska, Z ;

Niemirowska-Mikulska, H ;

Augustynowicz-Kopec, E ;

Walkiewicz, R ;

Stambrowska, H ;

Safianowska, A ;

Grubek-Jaworska, H .

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (10) :824-830

[34] Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects [J].

Kang, Woo Youl ;

Seong, Sook Jin ;

Ohk, Boram ;

Gwon, Mi-Ri ;

Kim, Bo Kyung ;

Cho, Seungil ;

Shim, Wang-Seob ;

Lee, Kyung-Tae ;

Kim, Eun Hee ;

Yang, Dong Heon ;

Lee, Hae Won ;

Yoon, Young-Ran .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 :3607-3615

[35] Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tablet [J].

Glund, Stephan ;

Mattheus, Michaela ;

Runge, Frank ;

Rose, Peter ;

Friedrich, Christian .

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (04) :355-367

[36] Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects [J].

Min, Kyoung Lok ;

Park, Min Soo ;

Jung, Jina ;

Chang, Min Jung ;

Kim, Choon Ok .

CLINICAL THERAPEUTICS, 2017, 39 (09) :1799-1810

[37] Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects [J].

Grill, Simon ;

Bruderer, Shirin ;

Sidharta, Patricia N. ;

Antonova, Mariya ;

Globig, Susanne ;

Carlson, James ;

Schultz, Armin ;

Csonka, Denes .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (12) :2424-2434

[38] Bioequivalence of saxagliptin/dapagliflozin fixed-dose combination tablets compared with coadministration of the individual tablets to healthy subjects [J].

Vakkalagadda, Blisse ;

Vetter, Marion L. ;

Rana, Jignasa ;

Smith, Charles H. ;

Huang, Jian ;

Karkas, Jennifer ;

Boulton, David W. ;

LaCreta, Frank .

PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (06) :1-12

[39] PHARMACOKINETICS AND PHARMACODYNAMICS OF GEMIGLIPTIN/ROSUVASTATIN FIXED-DOSE COMBINATION COMPARED WITH LOOSE COMBINATION OF INDIVIDUAL TABLETS IN HEALTHY SUBJECTS. [J].

Hwang, I. ;

Park, S-I ;

Park, K. ;

Yoon, S. ;

Jung, J. ;

Lee, S. ;

Lee, H. ;

Yu, K-S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) :S31-S31

[40] A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects [J].

Kim, Eunwoo ;

Park, Kyoung Ryun ;

Jang, In-Jin ;

Yu, Kyung-Sang ;

Lee, SeungHwan .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :3879-3885

← 1 2 3 4 5 →